Human Placenta-Derived Mesenchymal Stem Cells Ameliorate Diabetic Kidney Disease by Modulating the T Helper 17 Cell/ Regulatory T-Cell Balance through the Programmed Death 1 / Programmed Death-Ligand 1 Pathway

The authors investigated the therapeutic effects and immunomodulatory mechanisms of human placenta-derived mesenchymal stem cells in diabetic kidney disease.
[Diabetes Obesity & Metabolism]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News